SAN DIEGO, CA -- (MARKET WIRE) -- 04/28/2005 -- Pharmessen, Inc. today announced that their application for a registered trademark for SLIMTRAX as a Principal Food Supplement Product has been granted by the U.S. Patent and Trademark Office. Pharmessen Inc. received registration number 2,933,239.
"The granting of the trademark is an exciting addition to Pharmessen's expanding portfolio of products and will differentiate Pharmessen's products from our competitors," said Dr. Dusan Ninkov, President and Chairman of Pharmessen, Inc. Pharmessen Inc. is also planning to advance outside of the U.S. by registering Trademarks in Europe and Asia, where Pharmessen already exports its products. "Our goal is to make Pharmessen products recognizable worldwide," said Dr. Ninkov.
About Pharmessen Inc.
Pharmessen, Inc. is a global nutraceutical company that was formed to research, develop, produce, and market pure herbal supplements and compounds. At the core of Pharmessen's business are its patented encapsulation technology and "water activation" delay processes, which in combination enable the company's products to benefit from enhanced and extended potency. Utilizing this proprietary blending formula, the company effectively combines herbal oil extracts from organically grown plants to create novel supplements and compounds. Additional information can be found on our website, www.pharmessen.com.
Safe Harbor Statement
This release contains forward-looking statements with respect to the results of operations and business of Pharmessen Scientific, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.